UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000009539 |
|---|---|
| Receipt number | R000010360 |
| Scientific Title | Phase II study of Pemetrexed and Bevacizumab in Plutinum Unfit patients with untreated advanced non-squamous non-small cell lung cancer(OSAKA-LCSG1201) |
| Date of disclosure of the study information | 2012/12/13 |
| Last modified on | 2018/12/18 14:19:13 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2012/12/13 13:05:33 | ||
| 2 | Update | 2013/01/16 15:56:15 | Recruitment status |
|
| 3 | Update | 2014/12/13 11:19:15 | TEL Last name of contact person Last name of contact person Address TEL |
|
| 4 | Update | 2015/12/13 09:23:34 | Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
| 5 | Update | 2016/06/13 23:21:24 | Name of primary person or sponsor Organization |
|
| 6 | Update | 2018/12/18 14:19:13 | Recruitment status |
